New evidence demonstrated if 1,000 postmenopausal women at high risk of breast cancer took anastrozole for 5 years 35 cases of breast cancer would be prevented, compared to 21 if they took tamoxifen. Women at high risk who have not been through the menopause should continue to be offered tamoxifen.